{"schema_version":"1","generated_at":"2026-11-05T06:23:24.906Z","data_as_of":null,"url":"https://www.findmykol.com/kol/heidi-mckean","json_url":"https://www.findmykol.com/kol/heidi-mckean/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"heidi-mckean","name":"Heidi McKean","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Avera Health","institution_url":"https://www.findmykol.com/institution/avera-health","city":"Sioux Falls","state":"SD","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1992714281","openalex":"A5108690925"},"summary":"Heidi McKean is an Oncology physician affiliated with Avera Health. OpenAlex indexes 26 publications with 200 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":26,"cited_by_count":200,"h_index":7,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":32,"shown":3,"withheld":29,"rows":[{"payer":"Takeda","program_year":2025,"amount_usd":192801.3,"payment_count":22,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992714281"},{"payer":"Pfizer","program_year":2025,"amount_usd":191688.84,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992714281"},{"payer":"Merck & Co.","program_year":2025,"amount_usd":124933.8,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992714281"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1992714281","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":35.4,"classes_total":4,"classes":[{"class":"Cytochrome P450 17A1 Inhibitor","setting":"prescribed","share_pct":14.3,"drugs":[{"name":"Abiraterone Acetate","share_pct":100}],"max_beneficiaries":null},{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":8.2,"drugs":[{"name":"Anastrozole","share_pct":59.3},{"name":"Letrozole","share_pct":40.7}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":21.6,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":17.7,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":17},{"class":"Potassium supplement","setting":"prescribed","share_pct":4,"drugs":[{"name":"Potassium Chloride","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":21.3,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":17.4,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":11},{"class":"Vitamin K antagonist","setting":"prescribed","share_pct":4,"drugs":[{"name":"Warfarin Sodium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":23.5,"facility_pct":76.5},"source":"medicare"},"publications":{"total":26,"shown":5,"withheld":21,"matched_by":"OpenAlex author record","recent":[{"title":"Genomic and sociodemographic characterization of gastrointestinal cancers in rural patients participating in the Avera Cancer Sequencing and Analytics Protocol (ASAP).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.848","status":"verified"},{"title":"Association of lymphopenia rescue and CA19-9 levels with overall survival following IL-15 superagonist N-803 and PD-L1 t-haNK chemo-immunotherapy for 3 rd line or greater metastatic pancreatic cancer.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.2542","status":"verified"},{"title":"Impact of intrathecal targeted drug delivery (ITDD) on oral morphine equivalents and pain scores in advanced pancreatic cancer pain.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.4_suppl.686","status":"verified"},{"title":"Total neoadjuvant therapy for rectal cancer in the rural community oncology setting.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.3_suppl.41","status":"verified"},{"title":"Overall survival in patients with metastatic or locally advanced pancreatic cancer following chemoradiation with novel combination of aldoxorubicin, N-803 IL-15 superagonist, and PDL1- NK cell therapy.","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.4_suppl.720","status":"verified"}],"source":"works"},"contact":{"address_1":"1000 E. 23RD ST.","address_2":"STE. 230","city":"Sioux Falls","state":"SD","zip":"571052122","phone":"605-322-6900","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1992714281","source":"identity"},"similar":[{"name":"David Starks","slug":"david-starks","institution":"Avera Health","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/david-starks","json_url":"https://www.findmykol.com/kol/david-starks/profile.json"},{"name":"Amy Sanford","slug":"amy-sanford","institution":"Avera Health","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/amy-sanford","json_url":"https://www.findmykol.com/kol/amy-sanford/profile.json"},{"name":"Samir Abu-Ghazaleh","slug":"samir-abu-ghazaleh","institution":"Avera Health","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/samir-abu-ghazaleh","json_url":"https://www.findmykol.com/kol/samir-abu-ghazaleh/profile.json"},{"name":"Waqas Jehangir","slug":"waqas-jehangir","institution":"Avera Health","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/waqas-jehangir","json_url":"https://www.findmykol.com/kol/waqas-jehangir/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":29,"publications":21}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2014-07-31","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}